当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:30.21亿  总市值:63.51亿
流通股本:4323.42万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.73亿元,每股收益0.84元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益194872.57万元,未分配利润25546.32万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产253018.98万元,负债58146.41万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入627,526,589.12296,374,647.621,102,010,333.61811,377,889.62
营业总成本522,427,598.32245,523,164.31931,884,986.72696,947,815.87
其他经营收益
营业利润100,639,047.5643,139,300.44148,334,349.56102,287,565.17
利润总额100,843,826.9143,349,042.99148,018,153.98102,391,559.79
净利润73,406,059.5430,693,093.12117,426,163.5183,853,892.8
每股收益
其他综合收益2,453,798.93724,099.55-1,641,272.743,372,706.74
综合收益总额75,859,858.4731,417,192.67115,784,890.7787,226,599.54
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,335,754,043.11,707,237,377.892,208,723,169.252,160,696,619.69
非流动资产:
非流动资产合计194,435,725962,034,554.98209,311,949.15191,468,793.21
资产总计2,530,189,768.12,669,271,932.872,418,035,118.42,352,165,412.9
流动负债:
流动负债合计542,520,437.38593,692,231.04345,761,323.6316,007,191.11
非流动负债:
非流动负债合计38,943,676.5342,208,825.2345,151,331.1638,185,293.35
负债合计581,464,113.91635,901,056.27390,912,654.76354,192,484.46
所有者权益(或股东权益):
归属于母公司股东权益合计1,948,725,654.192,033,370,876.62,027,122,463.641,997,972,928.44
股东权益合计1,948,725,654.192,033,370,876.62,027,122,463.641,997,972,928.44
负债和股东权益合计2,530,189,768.12,669,271,932.872,418,035,118.42,352,165,412.9
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计631,163,417.65286,980,156.391,293,712,783.17889,986,877.02
经营活动现金流出小计615,051,229.06279,883,597.41,135,400,077.66789,436,921.65
经营活动产生的现金流量净额16,112,188.597,096,558.99158,312,705.51100,549,955.37
投资活动产生的现金流量:
投资活动现金流入小计2,001,219,043.6796,578,027.77694,277,207.16360,254,145.57
投资活动现金流出小计2,399,795,383.16838,293,599.56852,754,867.09710,003,767.26
投资活动产生的现金流量净额-398,576,339.49-741,715,571.79-158,477,659.93-349,749,621.69
筹资活动产生的现金流量:
筹资活动现金流入小计271,010,787.63231,501,858.62104,944,888.52112,168,202.17
筹资活动现金流出小计278,428,623.1546,780,197.83271,787,057.28247,785,514.5
筹资活动产生的现金流量净额-7,417,835.52184,721,660.79-166,842,168.76-135,617,312.33
汇率变动对现金及现金等价物的影响3,350,488.572,458,750.34-1,442,233.01-1,339,636.09
现金及现金等价物净增加额-386,531,497.85-547,438,601.67-168,449,356.19-386,156,614.74
期末现金及现金等价物余额710,089,200.4549,182,096.581,096,620,698.25878,913,439.7
补充资料:
现金及现金等价物的净增加额-386,531,497.85--168,449,356.19-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券崔少煜,祝嘉琦1.602.243.162025-09-05
信达证券唐爱金1.642.112.692025-08-24
开源证券余汝意,聂媛媛1.562.222.822025-08-24
TOP↑